FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nozar Azarnia

Research Profile

Chemicals & Drugs

Concepts & Ideas

Disorders

Physiology

Procedures

Antineoplastic Combined Chemotherapy Protocols

Co-author Network

Publications

TOP 3
Heinz-Josef Lenz; Eric Van Cutsem; Shirin Khambata-Ford; Robert J Mayer; Philip Gold; Philip Stella; Barry Mirtsching; Allen L Cohn; Andrew W Pippas; Nozar Azarnia; Zenta Tsuchihashi; David J Mauro; Eric K Rowinsky
Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines.
Gerald Batist; Lyndsay Harris; Nozar Azarnia; Lily Waiyee Lee; Pascual Daza-Ramirez
Improved anti-tumor response rate with decreased cardiotoxicity of non-pegylated liposomal doxorubicin compared with conventional doxorubicin in first-line treatment of metastatic breast cancer in patients who had received prior adjuvant doxorubicin: results of a retrospective analysis.
James A. Bonner; Paul M Harari; Jordi Giralt; Nozar Azarnia; Dong M Shin; Roger B Cohen; Christopher U Jones; Ranjan Sur; David Raben; Jacek Jassem; Roger Ove; Merrill S Kies; Jose Baselga; Hagop Youssoufian; Nadia Amellal; Eric K Rowinsky; K. Kian Ang
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nozar Azarnia (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Heinz-Josef Lenz; Eric Van Cutsem; Shirin Khambata-Ford; Robert J Mayer; Philip Gold; Philip Stella; Barry Mirtsching; Allen L Cohn; Andrew W Pippas; Nozar Azarnia; Zenta Tsuchihashi; David J Mauro; Eric K Rowinsky
Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(30):4914-21.
2006: Gerald Batist; Lyndsay Harris; Nozar Azarnia; Lily Waiyee Lee; Pascual Daza-Ramirez
Improved anti-tumor response rate with decreased cardiotoxicity of non-pegylated liposomal doxorubicin compared with conventional doxorubicin in first-line treatment of metastatic breast cancer in patients who had received prior adjuvant doxorubicin: results of a retrospective analysis.
Anti-cancer drugs 2006;17(5):587-95.
2006: James A. Bonner; Paul M Harari; Jordi Giralt; Nozar Azarnia; Dong M Shin; Roger B Cohen; Christopher U Jones; Ranjan Sur; David Raben; Jacek Jassem; Roger Ove; Merrill S Kies; Jose Baselga; Hagop Youssoufian; Nadia Amellal; Eric K Rowinsky; K. Kian Ang
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.
The New England journal of medicine 2006;354(6):567-78.
2005: Roy S Herbst; Matthew A Arquette; Dong M Shin; Karel Dicke; Everett E Vokes; Nozar Azarnia; Waun Ki Hong; Merrill S Kies
Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5578-87.
2004: S Chan; N Davidson; E Juozaityte; F Erdkamp; A Pluzanska; Nozar Azarnia; L W Lee
Phase III trial of liposomal doxorubicin and cyclophosphamide compared with epirubicin and cyclophosphamide as first-line therapy for metastatic breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(10):1527-34.
2002: Lyndsay Harris; Gerald Batist; Robert Belt; Douglas Rovira; Rudolph Navari; Nozar Azarnia; Lauri Welles; Eric P Winer
Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma.
Cancer 2002;94(1):25-36.
1999: Charles L Shapiro; T Ervin; Lauri Welles; Nozar Azarnia; J Keating; Daniel F Hayes
Phase II trial of high-dose liposome-encapsulated doxorubicin with granulocyte colony-stimulating factor in metastatic breast cancer. TLC D-99 Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(5):1435-41.
1999: Vicente Valero; Aman U Buzdar; Richard L Theriault; Nozar Azarnia; G A Fonseca; Jie Willey; Michael S Ewer; Ronald S Walters; B Mackay; Donald A Podoloff; Daniel J Booser; L W Lee; Gabriel N Hortobagyi
Phase II trial of liposome-encapsulated doxorubicin, cyclophosphamide, and fluorouracil as first-line therapy in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(5):1425-34.